Our results demonstrate that repeated rapastinel injection could alleviate depression-like behaviors similar with ketamine binding to NMDAR, which further activated the VGF/BDNF/TrkB/ERK pathway, thereby regulating protein translation (e.g., VGF and BDNF). Here, BDNF is linked to major depressive disorder.